Enveric Biosciences, Inc.
ENVB· Nasdaq
Filed May 2, 2013 · 10-Q · 32 days after period end · 0001477932-13-002079
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Net Income | -$4.70K | -$4.05K | -$11.08K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 2, 2013 · 32 d after period end